Concepedia

Kaspar F. Burri

KF

Statistics

Publications

11

Citations

1.5K

H-Index

11

Active since

1967

Affiliations

Roche (Switzerland)(Current)

Kaspar F. Burri is an author at Roche (Switzerland) specializing in medicinal chemistry, pharmacology, and organic chemistry.

Publications per year

1967–1997

11

Publications

11

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.

Martine Clozel, Volker Breu, Gillian A. Gray et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 668 citations

, , +15

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

Martine Clozel, Volker Breu, Kaspar F. Burri et al. · Nature · 1993 · 529 citations

, , +9

Preparation of macrolides via the Wittig reaction. A total synthesis of (-)-vermiculine

Kaspar F. Burri, Robert A. Cardone, Wen Yean Chen et al. · Journal of the American Chemical Society · 1978 · 69 citations

, , +7

[2.2. …] Metacyclophane

Kaspar F. Burri, W. Jenny · Helvetica Chimica Acta · 1967 · 45 citations

, , +14

In vitro characterisation of Ro 46‐8443, the first non‐peptide antagonist selective for the endothelin ET<sub>B</sub> receptor

Volker Breu, Martine Clozel, Kaspar F. Burri et al. · FEBS Letters · 1996 · 43 citations · Full text

, , +17

1–5 of 11